Different subtypes of uterine sarcoma require a separate therapeutic approach.
Uterine sarcomas include a variety of mono- and biphasic malignancies, whereas tumor biology varies from an indolent and hormone-sensitive growth pattern to an aggressive and nonresponsive disease that is inevitably fatal. Insight into these different entities has only been gained after careful analysis of clinical, pathologic and molecular characteristics during the last few years. Furthermore, the rarity of uterine sarcomas has motivated many to collect data from different subtypes and to report on the collective data in order to report on larger numbers. The current overview aims to provide insights of clinical importance into each type of uterine sarcoma, with a special emphasis on treatment modalities.
Amant
Frederic
F
UZ Gasthuisberg, Katholieke Universiteit Leuven, Division of Gynecological Oncology, Department of Obstetrics & Gynecology, UZ Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium. Frederic.amant@uz.kuleuven.ac.be.